499 related articles for article (PubMed ID: 19799864)
1. Plasma annexin A5 and microparticle phosphatidylserine levels are elevated in sickle cell disease and increase further during painful crisis.
van Tits LJ; van Heerde WL; Landburg PP; Boderie MJ; Muskiet FA; Jacobs N; Duits AJ; Schnog JB
Biochem Biophys Res Commun; 2009 Dec; 390(1):161-4. PubMed ID: 19799864
[TBL] [Abstract][Full Text] [Related]
2. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulating stromal-derived factor-1 levels in sickle cell disease.
Landburg PP; Nur E; Maria N; Brandjes DP; Biemond BJ; Schnog JB; Duits AJ;
Acta Haematol; 2009; 122(1):64-9. PubMed ID: 19816012
[TBL] [Abstract][Full Text] [Related]
4. Red blood cells may contribute to hypercoagulability in uraemia via enhanced surface exposure of phosphatidylserine.
Bonomini M; Sirolli V; Merciaro G; Antidormi T; Di Liberato L; Brummer U; Papponetti M; Cappelli P; Di Gregorio P; Arduini A
Nephrol Dial Transplant; 2005 Feb; 20(2):361-6. PubMed ID: 15598665
[TBL] [Abstract][Full Text] [Related]
5. Plasma levels of pentraxin-3, an acute phase protein, are increased during sickle cell painful crisis.
Nur E; van Beers EJ; Martina S; Cuccovillo I; Otten HM; Schnog JJ; Meijers JC; Mantovani A; Brandjes DP; Bottazzi B; Biemond BJ;
Blood Cells Mol Dis; 2011 Mar; 46(3):189-94. PubMed ID: 21256776
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea.
Conran N; Fattori A; Saad ST; Costa FF
Am J Hematol; 2004 Aug; 76(4):343-7. PubMed ID: 15282666
[TBL] [Abstract][Full Text] [Related]
7. Changes of phosphatidylserine distribution in human red blood cells during the process of loading sugars.
Quan GB; Liu MX; Ren SP; Zhang JG; Han Y
Cryobiology; 2006 Aug; 53(1):107-18. PubMed ID: 16762335
[TBL] [Abstract][Full Text] [Related]
8. The acceleration of the propagation phase of thrombin generation in patients with steady-state sickle cell disease is associated with circulating erythrocyte-derived microparticles.
Gerotziafas GT; Van Dreden P; Chaari M; Galea V; Khaterchi A; Lionnet F; Stankovic-Stojanovic K; Blanc-Brude O; Woodhams B; Maier-Redelsperger M; Girot R; Hatmi M; Elalamy I
Thromb Haemost; 2012 Jun; 107(6):1044-52. PubMed ID: 22535498
[TBL] [Abstract][Full Text] [Related]
9. Gender-specific and menstrual cycle dependent differences in circulating microparticles.
Toth B; Nikolajek K; Rank A; Nieuwland R; Lohse P; Pihusch V; Friese K; Thaler CJ
Platelets; 2007 Nov; 18(7):515-21. PubMed ID: 17957567
[TBL] [Abstract][Full Text] [Related]
10. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
11. Annexin A5 inhibits engulfment through internalization of PS-expressing cell membrane patches.
Kenis H; van Genderen H; Deckers NM; Lux PA; Hofstra L; Narula J; Reutelingsperger CP
Exp Cell Res; 2006 Apr; 312(6):719-26. PubMed ID: 16380116
[TBL] [Abstract][Full Text] [Related]
12. Detection of phosphatidylserine surface exposure on human erythrocytes using annexin V-ferrofluid.
Geldwerth D; Helley D; de Jong K; Sabolovic' D; Sestier C; Roger J; Pons JN; Freyssinet JM; Devaux PF; Kuypers FA
Biochem Biophys Res Commun; 1999 Apr; 258(1):199-203. PubMed ID: 10222260
[TBL] [Abstract][Full Text] [Related]
13. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
[TBL] [Abstract][Full Text] [Related]
14. Protein C and S and inflammation in sickle cell disease.
Schnog JB; Mac Gillavry MR; van Zanten AP; Meijers JC; Rojer RA; Duits AJ; ten Cate H; Brandjes DP
Am J Hematol; 2004 May; 76(1):26-32. PubMed ID: 15114593
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylserine exposure and other apoptotic-like events in Bernard-Soulier syndrome platelets.
Rand ML; Wang H; Bang KW; Teitel JM; Blanchette VS; Freedman J; Nurden AT
Am J Hematol; 2010 Aug; 85(8):584-92. PubMed ID: 20658588
[TBL] [Abstract][Full Text] [Related]
16. Lactadherin binding and phosphatidylserine expression on cell surface-comparison with annexin A5.
Dasgupta SK; Guchhait P; Thiagarajan P
Transl Res; 2006 Jul; 148(1):19-25. PubMed ID: 16887494
[TBL] [Abstract][Full Text] [Related]
17. The role of erythrocytes phosphatidylserine exposure in anemia in peritoneal dialysis patients.
Bi SH; Cheng LT; Wang T
Ren Fail; 2006; 28(7):573-6. PubMed ID: 17050240
[TBL] [Abstract][Full Text] [Related]
18. Loss of phospholipids asymmetry in red blood cells contributes to anemia in uremic patients.
Kong QY; Wu X; Li J; Peng WX; Ye R; Lindholm B; Wang T
Adv Perit Dial; 2001; 17():58-60. PubMed ID: 11510298
[TBL] [Abstract][Full Text] [Related]
19. Intradialytic and postdialytic platelet activation, increased platelet phosphatidylserine exposure and ultrastructural changes in platelets in children with chronic uremia.
Elshamaa MF; Elghoroury EA; Helmy A
Blood Coagul Fibrinolysis; 2009 Jun; 20(4):230-9. PubMed ID: 19521197
[TBL] [Abstract][Full Text] [Related]
20. Attenuating a sickle cell crisis with annexin V.
Kennedy JR
Med Hypotheses; 2015 May; 84(5):434-6. PubMed ID: 25665862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
